Literature DB >> 8830767

The hnRNP C proteins contain a nuclear retention sequence that can override nuclear export signals.

S Nakielny1, G Dreyfuss.   

Abstract

Nascent pre-mRNAs associate with the abundant heterogeneous nuclear RNP (hnRNP) proteins and remain associated with them throughout the time they are in the nucleus. The hnRNP proteins can be divided into two groups according to their nucleocytoplasmic transport properties. One group is completely restricted to the nucleus in interphase cells, whereas the other group, although primarily nuclear at steady state, shuttles between the nucleus and the cytoplasm. Nuclear export of the shuttling hnRNP proteins is mediated by nuclear export signals (NESs). Mounting evidence indicates that NES-bearing hnRNP proteins are mediators of mRNA export. The hnRNP C proteins are representative of the nonshuttling group of hnRNP proteins. Here we show that hnRNP C proteins are restricted to the nucleus not because they lack an NES, but because they bear a nuclear retention sequence (NRS) that is capable of overriding NESs. The NRS comprises approximately 78 amino acids and is largely within the auxiliary domain of hnRNP C1. We suggest that the removal of NRS-containing hnRNP proteins from pre-mRNA/mRNA is required for mRNA export from the nucleus and is an essential step in the pathway of gene expression.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8830767      PMCID: PMC2121000          DOI: 10.1083/jcb.134.6.1365

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  39 in total

1.  Epstein-Barr virus-induced autoimmune responses. I. Immunoglobulin M autoantibodies to proteins mimicking and not mimicking Epstein-Barr virus nuclear antigen-1.

Authors:  J H Vaughan; J R Valbracht; M D Nguyen; H H Handley; R S Smith; K Patrick; G H Rhodes
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

2.  A pre-mRNA-binding protein accompanies the RNA from the gene through the nuclear pores and into polysomes.

Authors:  N Visa; A T Alzhanova-Ericsson; X Sun; E Kiseleva; B Björkroth; T Wurtz; B Daneholt
Journal:  Cell       Date:  1996-01-26       Impact factor: 41.582

Review 3.  Conserved structures and diversity of functions of RNA-binding proteins.

Authors:  C G Burd; G Dreyfuss
Journal:  Science       Date:  1994-07-29       Impact factor: 47.728

4.  Primary structure of human nuclear ribonucleoprotein particle C proteins: conservation of sequence and domain structures in heterogeneous nuclear RNA, mRNA, and pre-rRNA-binding proteins.

Authors:  M S Swanson; T Y Nakagawa; K LeVan; G Dreyfuss
Journal:  Mol Cell Biol       Date:  1987-05       Impact factor: 4.272

5.  Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors.

Authors:  J F Cáceres; S Stamm; D M Helfman; A R Krainer
Journal:  Science       Date:  1994-09-16       Impact factor: 47.728

6.  Interaction of cellular factors with intragenic cis-acting repressive sequences within the HIV genome.

Authors:  H S Olsen; A W Cochrane; C Rosen
Journal:  Virology       Date:  1992-12       Impact factor: 3.616

7.  Characterization of cis-acting signals for nuclear import and retention of the La (SS-B) autoantigen.

Authors:  F H Simons; F J Broers; W J Van Venrooij; G J Pruijn
Journal:  Exp Cell Res       Date:  1996-05-01       Impact factor: 3.905

8.  Alternative splicing in the human gene for the core protein A1 generates another hnRNP protein.

Authors:  M Buvoli; F Cobianchi; M G Bestagno; A Mangiarotti; M T Bassi; G Biamonti; S Riva
Journal:  EMBO J       Date:  1990-04       Impact factor: 11.598

9.  RNA annealing activities in HeLa nuclei.

Authors:  D S Portman; G Dreyfuss
Journal:  EMBO J       Date:  1994-01-01       Impact factor: 11.598

10.  A nuclear localization domain in the hnRNP A1 protein.

Authors:  H Siomi; G Dreyfuss
Journal:  J Cell Biol       Date:  1995-05       Impact factor: 10.539

View more
  83 in total

1.  Polyuridylated mRNA synthesized by a recombinant influenza virus is defective in nuclear export.

Authors:  L L Poon; E Fodor; G G Brownlee
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Differentiation-induced internal translation of c-sis mRNA: analysis of the cis elements and their differentiation-linked binding to the hnRNP C protein.

Authors:  O Sella; G Gerlitz; S Y Le; O Elroy-Stein
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

3.  Nucleocytoplasmic shuttling: a novel in vivo property of antisense phosphorothioate oligodeoxynucleotides.

Authors:  P Lorenz; T Misteli; B F Baker; C F Bennett; D L Spector
Journal:  Nucleic Acids Res       Date:  2000-01-15       Impact factor: 16.971

Review 4.  Nuclear RNA export pathways.

Authors:  B R Cullen
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

5.  Role of the influenza virus M1 protein in nuclear export of viral ribonucleoproteins.

Authors:  M Bui; E G Wills; A Helenius; G R Whittaker
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

6.  The spliceosome deposits multiple proteins 20-24 nucleotides upstream of mRNA exon-exon junctions.

Authors:  H Le Hir; E Izaurralde; L E Maquat; M J Moore
Journal:  EMBO J       Date:  2000-12-15       Impact factor: 11.598

7.  Effects of poliovirus infection on nucleo-cytoplasmic trafficking and nuclear pore complex composition.

Authors:  K E Gustin; P Sarnow
Journal:  EMBO J       Date:  2001-01-15       Impact factor: 11.598

8.  Nuclear localization and shuttling of herpes simplex virus tegument protein VP13/14.

Authors:  M Donnelly; G Elliott
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

9.  An exon that prevents transport of a mature mRNA.

Authors:  M A MacMorris; D A Zorio; T Blumenthal
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

10.  TAP binds to the constitutive transport element (CTE) through a novel RNA-binding motif that is sufficient to promote CTE-dependent RNA export from the nucleus.

Authors:  I C Braun; E Rohrbach; C Schmitt; E Izaurralde
Journal:  EMBO J       Date:  1999-04-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.